|
|
Analysis of risk factors of acquired immunodeficiency syndrome complicated with tuberculosis infection |
XU Yuping1,2 TIAN Qun2 WANG Jiye3 |
1.Health Center of Guilin Medical College, Guangxi Zhuang Autonomous Region, Guilin 541004, China;
2.Infectious Disease Department, Guilin Third People′s Hospital, Guangxi Zhuang Autonomous Region, Guilin 541001, China;
3.Department of Respiratory and Critical Medicine, the Second People′s Hospital of Guilin, Guangxi Zhuang Autonomous Region, Guilin 541001, China |
|
|
Abstract Objective To explore the risk factors of acquired immunodeficiency syndrome (AIDS) complicated with tuberculosis infection. Methods A total of 3224 AIDS patients admitted to Guilin Third People′s Hospital of Cuangxi Zhuang Autonomous Region from January 2015 to November 2019 were selected as the subjects. According to the presence or absence of tuberculosis infection, they were divided into infection group (255 cases) and non infection group (2969 cases). The basic data and disease-related conditions were compared between the two groups. The risk factors of AIDS complicated with tuberculosis infection were analysed by multivariate related factors. Results The proportion of patients with smoking history, low family income, unemployment and intravenous drug use in the infection group were significantly higher than those in the non infection group (P < 0.05), while the proportion of patients with BCG vaccination history were significantly lower than that in the non infection group (P < 0.05). There were no significant differences between the two groups in age, gender, drinking history, education level, marital status, urban and rural distribution (P > 0.05). Multivariate logistic regression analysis showed that smoking history, unemployment, intravenous drug use were the independent risk factors of AIDS complicated with tuberculosis infection (P < 0.05), and BCG vaccination history was the protective factor of AIDS with tuberculosis infection (P < 0.05). Conclusion Low family income, unemployment, intravenous drug use, smoking history are the independent risk factors of AIDS with tuberculosis infection, while BCG vaccination is the protective factor of AIDS with tuberculosis infection.
|
|
|
|
|
[1] 黄灿.艾滋病药物治疗管理的研究进展[J].北京医学,2019,41(10):920-922.
[2] 宋韬,李莉娟,付洪义,等.结核感染T细胞斑点试验在肺结核合并艾滋病患者中的诊断和影响分析[J].中国临床医生杂志,2019,47(12):1429-1432.
[3] 李明瑛,王和林,丁卫民.艾滋病合并肺结核的临床特点分析[J].中国医刊,2019,37(7):723-726.
[4] 张林,王永素,苗瑞红,等.艾滋病合并肺结核病患者综合特征分析[J].临床肺科杂志,2019,24(12):2227-2230.
[5] Gao J,Zheng P,FU H. Prevalence of TB/HIV co-infection in countries except China:a systematic review and meta-analysis [J]. PloS One,2013,8(5):64915.
[6] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防与控制中心.中国艾滋病诊疗指南(2018版)[J].中华传染病杂志,2018,36(12):705-724.
[7] 中华医学会结核病学分会.肺结核诊断和治疗指南[J].中国实用乡村医生杂志,2013,20(2):7-11.
[8] 于晓敏.艾滋病合并肺结核的临床与CT表现分析及与其他肺部机会性感染的鉴别[D].广州:南方医科大学,2019.
[9] 崔哲哲,冯启明,林玫,等.2010~2013年广西TB/HIV双重感染监测数据分析与评价[J].广西医学,2015,37(3):364-367.
[10] Mitku AA,Dessie ZG,Muluneh EK,et al. Prevalence and associated factors of TB/HIV co-infection among HIV infected patients in Amhara region, Ethiopia [J]. Afr Health Sci,2016,16(2):588-595.
[11] 肖科,於琳,罗瑜,等.艾滋病合并痰菌涂阳肺结核病人临床分析[J].中国艾滋病性病,2018,24(11):1151-1153.
[12] 程勇祥,冯毅.艾滋病与结核病共感染患者肺结核治疗期间死亡的相关因素分析[J].湖南师范大学学报:医学版,2019,16(2):14-18.
[13] 刘水桂,肖勇,季苏萍.南昌市老年人群肺结核患病危险因素病例对照研究[J].预防医学,2016,28(12):1197-1199,1204.
[14] 寇艳,纪风兵,范凌,等.艾滋病合并肺结核双重感染的危险因素[J].江苏预防医学,2019,30(3):298-299,320.
[15] 白丽丽.沈阳市区老年初治肺结核常见易患因素分析[J].中国老年保健医学,2018,16(5):96-97.
[16] 赵良华,何文林,刘宏,等.四川省泸州市2016年肺结核流行现状及其影响因素分析[J].成都医学院学报,2018, 13(3):353-354,358.
[17] 贺湘焱.新疆肺结核流行特征及预防控制效果评价[D].乌鲁木齐:新疆医科大学,2017.
[18] 古丽洁米莱姆·阿木提.HIV/TB双重感染与单纯肺结核的临床分析[D].乌鲁木齐:新疆医科大学,2019.
[19] 马瑶,吴桂辉.156例HIV/TB患者治疗转归及死亡危险因素分析[J].临床肺科杂志,2019,24(10):1878-1882.
[20] 王云国.肺结核患者的发病情况和预防控制对策分析[J].世界最新医学信息文摘,2019,19(1):61.
[21] 宋韬,李莉娟,付洪义,等.结核感染T细胞斑点试验在肺结核合并艾滋病患者中的诊断和影响分析[J].中国临床医生杂志,2019,47(12):1429-1432.
[22] 蓝如束,赵锦明,成诗明,等.HIV感染与AIDS患者CD4~+T淋巴细胞计数与肺结核主要症状体征的相关性研究[J].中国防痨杂志,2013,357):529-532.
[23] 曾静,刘雪梅,画伟,等.艾滋病肺部机会性感染[J].中国医药导报,2018,15(4):31-34.
[24] 李智勇,李永春,陈焰,等.T-SPOT联合CD4~+T淋巴细胞计数早期诊断HIV/AIDS合并肺结核潜伏感染的诊断价值分析[J].中国医药科学,2018,8(1):22-25. |
|
|
|